Novo Holdings Catalent, Inc. Transaction History

Novo Holdings

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$45.44 - $74.26 $36.4 Million - $59.4 Million	-800,000 Reduced 48.99%	832,878 $54.7 Million
Q2 2022 Aug 15, 2022	BUY	$87.2 - $114.05 $31.5 Million - $41.2 Million	361,171 Added 28.4%	1,632,878 $175 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $120 Million - $158 Million	1,271,707 New	1,271,707 $141 Million
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $101 Million - $125 Million	-997,349 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $54 Million - $66.2 Million	-628,651 Reduced 38.66%	997,349 $104 Million
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $58.3 Million - $74.1 Million	801,261 Added 97.15%	1,626,000 $139 Million
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $39.6 Million - $65.2 Million	824,739 New	824,739 $60.5 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.